Silver Book Fact

Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.

Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1. AHRQ Web site. http://www.ahrq.gov/clinic/strokcln.htm. Published June 2000

Reference

Title
Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1
Publication
AHRQ
Publication Date
Published June 2000
Authors
Matchar, David, and Gregory Samsa
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • There are currently 312 medicines in development for heart disease and stroke.  
  • Heart Failure Disease Management (DM) Program Reduces Hospitalizations and Overall Costs  
  • Cardiovascular disease death rates
    Cardiovascular disease accounts for nearly 801,000 deaths in the US, or about 1 of every 3 deaths in the US.  
  • If all forms of cardiovascular disease were eliminated, life expectancy would rise by almost 7 years.  
  • Hospitalization from incorrect diagnosis of heart attacks costs $12 billion per year. If creatine kinase, myoglobin and troponin are used for detecting heart attack in ER patients with chest pain,…